• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中低收入国家与高收入国家静脉血栓栓塞发生率的差异。

Variations in incidence of venous thromboembolism in low-, middle-, and high-income countries.

机构信息

Population Health Research Institute, DBCVSRI, Hamilton General Hospital, 237 Barton St. East, Hamilton, ON L8L 2X2, Canada.

McMaster University, Hamilton, ON, Canada.

出版信息

Cardiovasc Res. 2021 Jan 21;117(2):576-584. doi: 10.1093/cvr/cvaa044.

DOI:10.1093/cvr/cvaa044
PMID:32142099
Abstract

AIMS

To examine the rates of venous thromboembolism (VTE) in high-income, upper middle-income, and lower middle/low-income countries (World Bank Classification).

METHODS AND RESULTS

We examined the rates of VTE in high-income, upper middle-income, and lower middle/low-income countries (World Bank Classification) in a cohort derived from four prospective international studies (PURE, HOPE-3, ORIGIN, and COMPASS). The primary outcome was a composite of pulmonary embolism, deep vein thrombosis, and thrombophlebitis. We calculated age- and sex-standardized incidence rates (per 1000 person-years) and used a Cox frailty model adjusted for covariates to examine associations between the incidence of VTE and country income level. A total of 215 307 individuals (1.5 million person-years of follow-up) from high-income (n = 60 403), upper middle-income (n = 42 066), and lower middle/low-income (n = 112 838) countries were included. The age- and sex-standardized incidence rates of VTE per 1000 person-years in high-, upper middle-, and lower middle/low-income countries were 0.87, 0.25, and 0.06, respectively. After adjusting for age, body mass index (BMI), smoking, antiplatelet therapy, anticoagulant therapy, education level, ethnicity, and incident cancer diagnosis or hospitalization, individuals from high-income and upper middle-income countries had a significantly higher risk of VTE than those from lower middle/low-income countries [hazard ratio (HR) 3.57, 95% confidence interval (CI) 2.40-5.30 and HR 2.27, 95% CI 1.59-3.23, respectively]. The effect of country income level on VTE risk was markedly stronger in people with a lower BMI, hypertension, diabetes, non-White ethnicity, and higher education.

CONCLUSION

The rates of VTE are substantially higher in high-income than in low-income countries. The factors underlying the increased VTE risk in higher-income countries remain unknown.

摘要

目的

检查高收入、中上收入和中下等收入/低收入国家(世界银行分类)的静脉血栓栓塞症(VTE)发生率。

方法和结果

我们在四项前瞻性国际研究(PURE、HOPE-3、ORIGIN 和 COMPASS)中得出的队列中检查了高收入、中上收入和中下等收入/低收入国家(世界银行分类)的 VTE 发生率。主要结局是肺栓塞、深静脉血栓形成和血栓性静脉炎的复合。我们计算了年龄和性别标准化的发病率(每 1000 人年),并使用 Cox 脆弱模型调整了协变量,以检查 VTE 发生率与国家收入水平之间的关联。共有 215307 名个体(150 万人年随访)来自高收入(n=60403)、中上收入(n=42066)和中下等收入/低收入(n=112838)国家。高、中上和中下等收入/低收入国家每 1000 人年的 VTE 年龄和性别标准化发病率分别为 0.87、0.25 和 0.06。在校正年龄、体重指数(BMI)、吸烟、抗血小板治疗、抗凝治疗、教育水平、种族以及新发癌症诊断或住院治疗后,来自高收入和中上收入国家的个体发生 VTE 的风险明显高于来自中下等收入/低收入国家的个体[风险比(HR)3.57,95%置信区间(CI)2.40-5.30 和 HR 2.27,95%CI 1.59-3.23]。在 BMI 较低、高血压、糖尿病、非白人种族和受教育程度较高的人群中,国家收入水平对 VTE 风险的影响更为显著。

结论

VTE 在高收入国家的发生率明显高于低收入国家。高收入国家 VTE 风险增加的潜在因素尚不清楚。

相似文献

1
Variations in incidence of venous thromboembolism in low-, middle-, and high-income countries.中低收入国家与高收入国家静脉血栓栓塞发生率的差异。
Cardiovasc Res. 2021 Jan 21;117(2):576-584. doi: 10.1093/cvr/cvaa044.
2
Venous thromboembolism and subsequent permanent work-related disability.静脉血栓栓塞症及随后的永久性与工作相关的残疾。
J Thromb Haemost. 2016 Oct;14(10):1978-1987. doi: 10.1111/jth.13411. Epub 2016 Aug 17.
3
Incidence and Risk Factors of Pulmonary Hypertension After Venous Thromboembolism: An Analysis of a Large Health Care Database.静脉血栓栓塞后肺动脉高压的发生率和危险因素:大型医疗保健数据库分析。
J Am Heart Assoc. 2022 Jul 19;11(14):e024358. doi: 10.1161/JAHA.121.024358. Epub 2022 Jul 15.
4
Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study.静脉血栓栓塞的风险因素:来自哥本哈根城市心脏研究的结果。
Circulation. 2010 May 4;121(17):1896-903. doi: 10.1161/CIRCULATIONAHA.109.921460. Epub 2010 Apr 19.
5
The Risk of Venous Thromboembolism in Patients with Gallstones.患有胆结石患者的静脉血栓栓塞风险。
Int J Environ Res Public Health. 2020 Apr 23;17(8):2930. doi: 10.3390/ijerph17082930.
6
Orthostatic Hypotension and Risk of Venous Thromboembolism in 2 Cohort Studies.两项队列研究中的直立性低血压与静脉血栓栓塞风险
Am J Hypertens. 2016 May;29(5):634-40. doi: 10.1093/ajh/hpv151. Epub 2015 Aug 25.
7
Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study.活动性癌症患者首次及复发性静脉血栓栓塞的流行病学。一项基于人群的队列研究。
Thromb Haemost. 2017 Jan 5;117(1):57-65. doi: 10.1160/TH15-08-0686. Epub 2016 Oct 6.
8
Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.HIV 感染者复发性静脉血栓栓塞的风险:一项全国性队列研究。
PLoS Med. 2020 May 14;17(5):e1003101. doi: 10.1371/journal.pmed.1003101. eCollection 2020 May.
9
American Heart Association's Life's Simple 7 and risk of venous thromboembolism: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.美国心脏协会的“生活简单7要素”与静脉血栓栓塞风险:中风地理和种族差异原因(REGARDS)研究
J Am Heart Assoc. 2015 Feb 27;4(3):e001494. doi: 10.1161/JAHA.114.001494.
10
Risk of venous thromboembolism in knee, hip and hand osteoarthritis: a general population-based cohort study.膝关节、髋关节和手部骨关节炎患者静脉血栓栓塞风险:一项基于普通人群的队列研究。
Ann Rheum Dis. 2020 Dec;79(12):1616-1624. doi: 10.1136/annrheumdis-2020-217782. Epub 2020 Sep 16.

引用本文的文献

1
The Recurrence of Venous Thromboembolism in Obstructive Sleep Apnea: A Narrative Review.阻塞性睡眠呼吸暂停患者静脉血栓栓塞的复发:一项叙述性综述。
Can Respir J. 2025 Jul 10;2025:8848869. doi: 10.1155/carj/8848869. eCollection 2025.
2
Efficacy and safety of anticoagulants on venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials.抗凝剂治疗静脉血栓栓塞症的疗效与安全性:一项随机对照试验的系统评价和网状荟萃分析
Front Pharmacol. 2025 Jan 8;15:1519869. doi: 10.3389/fphar.2024.1519869. eCollection 2024.
3
Incidental venous thrombosis in oncology in a sub-Saharan tertiary hospital.
撒哈拉以南一家三级医院肿瘤患者中的偶然静脉血栓形成
Ecancermedicalscience. 2024 Nov 7;18:1793. doi: 10.3332/ecancer.2024.1793. eCollection 2024.
4
Adequacy of Venous Thromboembolism Risk Assessment and Prophylaxis After Gastrointestinal Surgery in a Sudanese Teaching Hospital: A Prospective Audit.苏丹一家教学医院胃肠道手术后静脉血栓栓塞风险评估与预防的充分性:一项前瞻性审计
Cureus. 2024 Nov 9;16(11):e73316. doi: 10.7759/cureus.73316. eCollection 2024 Nov.
5
Impact of thyroid function on coagulation and venous thromboembolism: a two-sample mendelian randomization study.甲状腺功能对凝血和静脉血栓栓塞的影响:两样本孟德尔随机研究。
J Thromb Thrombolysis. 2024 Oct;57(7):1145-1153. doi: 10.1007/s11239-024-03025-7. Epub 2024 Aug 7.
6
Analysis of PROS1 mutations and clinical characteristics in three Chinese families with hereditary protein S deficiency.遗传性蛋白 S 缺乏症三大家系 PROS1 基因突变分析及临床特征
Ann Hematol. 2024 Feb;103(2):653-662. doi: 10.1007/s00277-023-05607-6. Epub 2024 Jan 4.
7
Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry.在一项国际登记研究中,高收入国家住院成人与低收入和中等收入国家住院成人相比,新型冠状病毒肺炎的血栓形成和出血并发症情况。
Res Pract Thromb Haemost. 2023 Jul 1;7(5):102142. doi: 10.1016/j.rpth.2023.102142. eCollection 2023 Jul.
8
Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries.疫苗诱导的免疫性血栓性血小板减少症导致的中等收入国家的颅内静脉窦血栓形成。
Int J Stroke. 2023 Oct;18(9):1112-1120. doi: 10.1177/17474930231182901. Epub 2023 Jun 30.
9
A review of the current literature of ethnic, gender, and socioeconomic disparities in venous disease.静脉疾病的种族、性别和社会经济差异的当前文献综述。
J Vasc Surg Venous Lymphat Disord. 2023 Jul;11(4):682-687. doi: 10.1016/j.jvsv.2023.03.006. Epub 2023 Apr 21.
10
A bibliometric analysis of the theme trends and knowledge structures of pulmonary embolism from 2017 to 2021.2017年至2021年肺栓塞主题趋势与知识结构的文献计量分析
Front Med (Lausanne). 2023 Feb 23;10:1052928. doi: 10.3389/fmed.2023.1052928. eCollection 2023.